Patheon (TSX:PTI; www.patheon.com), a global provider of drug development and manufacturing services to the international pharmaceutical industry, today announced that it has selected locations in the Wake County side of Research Triangle Park (RTP) and Durham, N.C., for its global headquarters and new analytical development laboratory facilities.
Patheon Inc. is a provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world’s leading pharmaceutical and biotechnology companies. Patheon’s services range from preclinical development through commercial manufacturing of a full array of dosage forms, including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies, including single-use disposables, liquid-filled hard capsules and a variety of modified release technologies.
Patheon’s comprehensive range of fully integrated pharmaceutical development services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services. Patheon’s Quick to Clinic™ programs can accelerate early phase development projects to clinical trials while minimizing the consumption of valuable API.
Patheon’s integrated development and manufacturing network of 11 facilities, and six development centers across North America and Europe, strives to ensure that customer products can be launched with confidence anywhere in the world.
Conni Tucker and Wayne Watkins with Wake County Economic Development worked on the project with Vivian Powell of the North Carolina Department of Commerce and Loren Kennedy of Kennedy Advisors. For additional information on the project, contact Wayne Watkins at 919.664.7043 or email@example.com.